Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants

View this webinar to learn more about: ? Factors driving the importance of biomarkers in immuno-oncology development ? How to leverage key technologies - flow cytometry, immunohistochemistry and next-generation sequencing ? A real-world example of how to tackle the challenge of effective patient recruitment ? The best way to engage a CRO / lab partner and access biomarker assays, solutions and disease state expertise